Tenaya Therapeutics (TNYA) Competitors $0.64 -0.05 (-7.14%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$0.64 +0.00 (+0.09%) As of 03/28/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TNYA vs. LFCR, ENGN, FHTX, MNPR, YMAB, NVCT, INMB, KRRO, ELDN, and DMACShould you be buying Tenaya Therapeutics stock or one of its competitors? The main competitors of Tenaya Therapeutics include Lifecore Biomedical (LFCR), enGene (ENGN), Foghorn Therapeutics (FHTX), Monopar Therapeutics (MNPR), Y-mAbs Therapeutics (YMAB), Nuvectis Pharma (NVCT), INmune Bio (INMB), Korro Bio (KRRO), Eledon Pharmaceuticals (ELDN), and DiaMedica Therapeutics (DMAC). These companies are all part of the "pharmaceutical products" industry. Tenaya Therapeutics vs. Lifecore Biomedical enGene Foghorn Therapeutics Monopar Therapeutics Y-mAbs Therapeutics Nuvectis Pharma INmune Bio Korro Bio Eledon Pharmaceuticals DiaMedica Therapeutics Tenaya Therapeutics (NASDAQ:TNYA) and Lifecore Biomedical (NASDAQ:LFCR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, community ranking, valuation, profitability, risk, dividends, earnings and analyst recommendations. Do analysts prefer TNYA or LFCR? Tenaya Therapeutics presently has a consensus price target of $6.25, suggesting a potential upside of 872.91%. Lifecore Biomedical has a consensus price target of $8.00, suggesting a potential upside of 16.79%. Given Tenaya Therapeutics' stronger consensus rating and higher possible upside, equities analysts plainly believe Tenaya Therapeutics is more favorable than Lifecore Biomedical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tenaya Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Lifecore Biomedical 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Do institutionals & insiders hold more shares of TNYA or LFCR? 90.5% of Tenaya Therapeutics shares are owned by institutional investors. Comparatively, 83.4% of Lifecore Biomedical shares are owned by institutional investors. 32.8% of Tenaya Therapeutics shares are owned by insiders. Comparatively, 32.2% of Lifecore Biomedical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is TNYA or LFCR more profitable? Tenaya Therapeutics has a net margin of 0.00% compared to Lifecore Biomedical's net margin of -12.52%. Tenaya Therapeutics' return on equity of -86.17% beat Lifecore Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Tenaya TherapeuticsN/A -86.17% -71.14% Lifecore Biomedical -12.52%-315.23%-12.74% Does the media favor TNYA or LFCR? In the previous week, Tenaya Therapeutics had 12 more articles in the media than Lifecore Biomedical. MarketBeat recorded 15 mentions for Tenaya Therapeutics and 3 mentions for Lifecore Biomedical. Tenaya Therapeutics' average media sentiment score of 0.96 beat Lifecore Biomedical's score of 0.89 indicating that Tenaya Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tenaya Therapeutics 4 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lifecore Biomedical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation and earnings, TNYA or LFCR? Lifecore Biomedical has higher revenue and earnings than Tenaya Therapeutics. Lifecore Biomedical is trading at a lower price-to-earnings ratio than Tenaya Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTenaya TherapeuticsN/AN/A-$124.08M-$1.32-0.49Lifecore Biomedical$130.86M1.94$12.01M-$0.56-12.23 Does the MarketBeat Community believe in TNYA or LFCR? Tenaya Therapeutics received 38 more outperform votes than Lifecore Biomedical when rated by MarketBeat users. Likewise, 83.67% of users gave Tenaya Therapeutics an outperform vote while only 25.00% of users gave Lifecore Biomedical an outperform vote. CompanyUnderperformOutperformTenaya TherapeuticsOutperform Votes4183.67% Underperform Votes816.33%Lifecore BiomedicalOutperform Votes325.00% Underperform Votes975.00% Which has more volatility & risk, TNYA or LFCR? Tenaya Therapeutics has a beta of 2.83, meaning that its stock price is 183% more volatile than the S&P 500. Comparatively, Lifecore Biomedical has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500. SummaryTenaya Therapeutics beats Lifecore Biomedical on 13 of the 17 factors compared between the two stocks. Remove Ads Get Tenaya Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TNYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNYA vs. The Competition Export to ExcelMetricTenaya TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$56.26M$3.03B$5.64B$7.84BDividend YieldN/A1.55%4.59%4.01%P/E Ratio-0.4529.4223.4118.71Price / SalesN/A429.55387.8590.69Price / CashN/A168.6838.1734.64Price / Book0.313.926.894.23Net Income-$124.08M-$71.95M$3.20B$247.26M7 Day Performance0.91%-5.60%-3.01%-2.21%1 Month Performance-36.40%-12.02%1.55%-5.74%1 Year Performance-87.72%-27.84%9.37%-0.80% Tenaya Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNYATenaya Therapeutics4.1036 of 5 stars$0.64-7.1%$6.25+872.9%-87.7%$56.26MN/A-0.45110Short Interest ↓Analyst RevisionNews CoverageLFCRLifecore Biomedical1.365 of 5 stars$6.58+0.5%$8.00+21.5%+29.0%$242.88M$130.86M-11.71690News CoverageENGNenGene3.1945 of 5 stars$4.66-6.0%$25.22+441.2%-74.6%$237.55MN/A-8.0331FHTXFoghorn Therapeutics2.6321 of 5 stars$4.24+4.6%$13.17+210.9%-47.5%$233.85M$22.60M-2.19120Positive NewsGap UpMNPRMonopar Therapeutics1.1825 of 5 stars$37.44-6.4%$44.00+17.5%+1,084.4%$228.46MN/A-19.0010Gap UpYMABY-mAbs Therapeutics3.6806 of 5 stars$5.06+1.2%$18.30+261.7%-70.4%$228.40M$87.69M-9.35150NVCTNuvectis Pharma2.6292 of 5 stars$9.68-5.1%$15.00+55.0%+27.6%$226.44MN/A-8.348INMBINmune Bio1.7312 of 5 stars$8.32+2.4%$22.80+174.2%-36.0%$220.33M$42,000.00-3.8010Earnings ReportNews CoverageKRROKorro Bio1.4889 of 5 stars$23.45-1.3%$142.57+508.1%-80.6%$220.13M$2.27M-2.5070Gap UpELDNEledon Pharmaceuticals1.7761 of 5 stars$3.63+3.3%$12.50+244.8%+62.6%$216.26MN/A-1.8010Analyst RevisionNews CoverageDMACDiaMedica Therapeutics1.6829 of 5 stars$5.02+0.8%$8.00+59.4%+37.9%$214.92MN/A-8.9620 Remove Ads Related Companies and Tools Related Companies Lifecore Biomedical Competitors enGene Competitors Foghorn Therapeutics Competitors Monopar Therapeutics Competitors Y-mAbs Therapeutics Competitors Nuvectis Pharma Competitors INmune Bio Competitors Korro Bio Competitors Eledon Pharmaceuticals Competitors DiaMedica Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNYA) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenaya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenaya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
